NASDAQ stocks with falls: (NLST, NAND, IBCP, PWAV, AVNR)

NASDAQ stocks with falls: (NLST, NAND, IBCP, PWAV, AVNR)

Netlist, Inc. (NASDAQ: NLST) gained by 9.97% and closed at $3.2 whereas overall traded volume stood at 1.98 million shares. Netlist, Inc. designs, manufactures and sells memory subsystems for the server, high performance computing and communications markets. The Company’s memory subsystems consist of combinations of dynamic random access memory integrated circuits, (DRAM ICs), Not And (NAND) flash memory (NAND), application-specific integrated circuits (ASICs) and other components assembled on printed circuit boards (PCBs). The Company’s memory products include DRAM Modules, RDIMM, FBDIMM, SODIMM, Mini-RDIMM, and NAND Flash Memory Cards and Modules.

United Community Banks, Inc. (NASDAQ: UCBI) closed at $3.4 after increasing by 3.34% with total traded volume of 1.98 million shares in the last trading day. United Community Banks, Inc. (United) is a bank holding company. United conducts its operations through 27 separate community banks, which as of December 31, 2009, operated at 107 locations in north Georgia, the Atlanta, Georgia Metropolitan Statistical Area (MSA), the Gainesville, Georgia MSA, coastal Georgia, western North Carolina and east Tennessee. The community banks offer a range of retail and corporate banking services, including checking, savings, and time deposit accounts, secured and unsecured loans, wire transfers, brokerage services, and other financial services. On June 19, 2009, United Community Bank (the Bank) announced the acquisition of Southern Community Bank from the Federal Deposit Insurance Corporation (FDIC).

Independent Bank Corporation(MI) (NASDAQ: IBCP) went up by 7.90% and closed at $0.34 whereas traded volume stood at 1.94 million shares for the day. Independent Bank Corporation is a bank holding company. The Company owns Independent Bank (the Bank). The Bank’s activities cover all phases of banking, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending and safe deposit box services. Its mortgage lending activities are primarily conducted through a separate mortgage bank subsidiary. Mepco Finance Corporation, a subsidiary of the Bank, acquires (on a full recourse basis) and services payment plans used by consumers to purchase vehicle service contracts and similar products provided and administered by third parties. In addition, the Bank offers title insurance services through a separate subsidiary and provides investment and insurance services through a third party agreement with PrimeVest Financial Services, Inc. The Bank serves its markets through its main office and a total of 105 branches, four drive-thru facilities and five loan production offices.

Powerwave Technologies, Inc. (NASDAQ: PWAV) reported the gain of 2.02% to close at $2.02 with overall traded volume of 1.91 million shares in the last trading session. Powerwave Technologies, Inc. (Powerwave) is a global supplier of end-to-end wireless solutions for wireless communications networks. The Company’s business consists of the design, manufacture, marketing and sale of products to improve coverage, capacity and data speed in wireless communications networks, including antennas, boosters, combiners, cabinets, shelters, filters, radio frequency power amplifiers, remote radio head transceivers, repeaters, tower-mounted amplifiers and advanced coverage solutions. The products are utilized in wireless networks globally, which support voice and data communications by use of cell phones and other wireless communication devices. Powerwave sell the products to both original equipment manufacturers, which incorporate the products into their base stations.

AVANIR Pharmaceuticals (NASDAQ: AVNR) jumped up by 1.52% and closed at $3.35 whereas total traded volume stood at 1.79 million shares. Avanir Pharmaceuticals, Inc. (Avanir) is a pharmaceutical company focused on acquiring, developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company’s lead product candidate, Zenvia (dextromethorphan hydrobromide/quinidine sulfate), has completed three Phase III clinical trials for the treatment of pseudobulbar affect (PBA) and has completed a Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain (DPN pain). In addition to its focus on products for the central nervous system, Avanir also has a number of partnered programs in other therapeutic areas. Its product, docosanol 10% cream, (sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare) is an over-the-counter treatment for cold sores that has been approved by the United States Food and Drug Administration (FDA).

Share This:

Leave a Reply

Your email address will not be published. Required fields are marked *